Loading company…
Syrrx develops tools for high-throughput structure determination and screening.
Syrrx develops research tools for high-throughput structure determination and screening. Its products support studies of molecular mechanisms, cellular functions and immune responses. The company is based in San Diego, US. Takeda Pharmaceutical Company Limited acquired it in February 2005 for USD 270 mn.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in